Marimed (MRMD) Receivables - Net (2011 - 2026)

Marimed (MRMD) has 15 years of Receivables - Net data on file, last reported at $9.4 million in Q1 2026.

• Receivables - Net for Q1 2026 came in at $9.4 million, up 2.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.4 million (up 2.8% YoY), and the FY2025 annual result was $9.1 million, up 4.26% from the prior year.
• Receivables - Net advanced to $9.4 million in Q1 2026 per MRMD's latest filing, from $9.1 million in the prior quarter.
• Over five years, Receivables - Net peaked at $9.4 million in Q1 2026 and troughed at $3.5 million in Q1 2022.
• A 5-year average of $6.9 million and a median of $7.2 million in 2023 frame the typical range for Receivables - Net.
• On a YoY basis, Receivables - Net climbed as much as 149.52% in 2022 and fell as far as 52.84% in 2022.
• A 5-year view of Receivables - Net shows it stood at $4.2 million in 2022, then jumped by 73.18% to $7.2 million in 2023, then gained by 21.43% to $8.7 million in 2024, then increased by 4.26% to $9.1 million in 2025, then rose by 3.57% to $9.4 million in 2026.
• Business Quant data shows MRMD's Receivables - Net at $9.4 million in Q1 2026, $9.1 million in Q4 2025, and $8.0 million in Q3 2025.